DRUG_TARGET,effect,color,SUBTYPE,pval,neg_log10p,ORDER,target,pathway,NEW_ORDER,AZD8931 (ERBB1/2/3),-17.56801183,red,BL1,0.036198378,1.441310883,79,ERBB1/2/3,RTK,1,EPZ004777 (Dot1L),-2.930534973,red,BL1,0.209349089,0.679128924,61,Dot1L,chromatin,2,Vorinostat (HDAC),-2.906604784,red,BL1,0.012251594,1.911807415,71,HDAC,chromatin,3,BX-795 (AURKB/C),-2.640141816,red,BL1,0.020390493,1.690572283,65,AURKB/C,mitosis,4,CHIR-99021 (GSK3B),-2.557775895,red,BL1,0.023839234,1.622707711,41,GSK3B,WNT signaling,5,Gemcitibine (DNA replication),-2.534392764,red,BL1,0.029646797,1.528022216,64,DNA replication,DNA replication,6,Bortezomib (Proteasome),-2.396374045,red,BL1,0.251673745,0.599162088,91,Proteasome,other,7,MLN8237 (AURKA),-2.373770071,red,BL1,0.253825231,0.59546521,56,AURKA,mitosis,8,Erlotinib (EGFR),-2.201767317,red,BL1,0.07891807,1.102823546,51,EGFR,RTK,9,YK 4-279 (RNA helicase A),-1.99407156,red,BL1,0.074116419,1.130085572,92,RNA helicase A,other,10,Camptothecin (TOP1),-1.948159243,red,BL1,0.071730877,1.144293858,81,TOP1,DNA replication,11,Nutlin-3a (MDM2),-1.860112296,red,BL1,0.085640205,1.067322303,12,MDM2,p53 pathway,12,BMS-536924 (IGF-1R),-1.790856799,red,BL1,0.096616952,1.014946667,40,IGF-1R,IGFR,13,BI-2536 (PLK1/2/3),-1.704175418,red,BL1,0.119167494,0.923842194,69,PLK1/2/3,mitosis,14,BMN-673 (PARP1),-1.681554072,red,BL1,0.123570338,0.908085765,35,PARP1,DNA replication,15,PD-173074 (FGFR1/3),-1.535092449,red,BL1,0.148733943,0.82758991,9,FGFR1/3,RTK,16,"Obatoclax Mesylate (BCL-2/-XL, MCL-1)",-1.510688183,red,BL1,0.154787742,0.810263434,53,"BCL-2/-XL, MCL-1",apoptosis,17,Vinblastine (Microtubules),-1.379542765,red,BL1,0.190996136,0.718975418,52,Microtubules,mitosis,18,JQ1 (BRD2/3/4),-1.364712896,red,BL1,0.195499757,0.708853777,4,BRD2/3/4,chromatin,19,NVP-AUY922 (HSP90),24.31853782,red,BL1,0.026163633,1.582301944,30,HSP90,AR,20,NVP-BEZ235 (PI3K/mTORC1/2),1.93438377,red,BL1,0.075131346,1.124178829,84,PI3K/mTORC1/2,PI3K_mTOR,21,OSI-906 (IGF1R),0.582154901,red,BL1,0.5733523,0.241578441,89,IGF1R,IGFR,22,Bicalutamide (AR),0.909059025,red,BL1,0.38470485,0.414872339,33,AR,AR,23,PLX4720 (BRAF),0.676797108,red,BL1,0.510398555,0.292090564,58,BRAF,BRAF,24,PF-562271 (FAK),-0.073050408,red,BL1,0.943206507,0.025393212,93,FAK,cytoskeleton,25,GDC0941 (PI3K),1.151738091,red,BL1,0.26871829,0.570702772,43,PI3K,PI3K_mTOR,26,Everolimus (mTOR),2.595843313,red,BL1,0.048492672,1.314323886,25,mTOR,PI3K_mTOR,27,AZ960 (JAK2),0.37330587,red,BL1,0.716712586,0.144654969,31,JAK2,other,28,AZD8055 (mTORC1/2),1.281996509,red,BL1,0.222235464,0.653186635,70,mTORC1/2,RTK,29,GSK2118436 (BRAF),0.764266735,red,BL1,0.46236096,0.335018843,45,BRAF,BRAF,30,LY317615 (PKC beta),0.705130104,red,BL1,0.496824603,0.303796906,95,PKC beta,other,31,Cyclophosphamide (DNA akyl),0.903214015,red,BL1,0.407818297,0.389533293,67,DNA akyl,DNA replication,32,Bryostatin (PKC),2.335650746,red,BL1,0.101623238,0.993006971,2,PKC,other,33,Temozolomide (DNA akyl),0.322430526,red,BL1,0.760172324,0.119087946,72,DNA akyl,DNA replication,34,ZM-447439 (AURKB),1.677242207,red,BL1,0.117360714,0.930477256,27,AURKB,mitosis,35,PF-4708671 (p70(RSK)),1.626990086,red,BL1,0.127722258,0.893733412,80,p70(RSK),RTK,36,Carboplatin (DNA akyl),-0.19826592,red,BL1,0.850646217,0.070251025,86,DNA akyl,DNA replication,37,Anastrozole (ER),-0.125537022,red,BL1,0.902177088,0.044708206,55,ER,other,39,Axitinib (multi-RTK),1.003495972,red,BL1,0.33393531,0.476337656,1,multi-RTK,RTK,40,SB-505124 (TGFbetaR-I),-1.037669028,red,BL1,0.318340721,0.497107804,3,TGFbetaR-I,other,42,JNK Inhibitor VIII (JNK),-0.01278417,red,BL1,0.989994098,0.004367394,5,JNK,JNK and p38,44,EHT 1864 (Rac GTPases),0.448645675,red,BL1,0.663252354,0.1783212,6,Rac GTPases,cytoskeleton,45,BIRB 0796 (p38/JNK2),0.494652843,red,BL1,0.629099289,0.201280806,7,p38/JNK2,JNK and p38,46,AICAR (AMPK agonist),0.547950968,red,BL1,0.603497673,0.2193244,8,AMPK agonist,metabolism,47,CEP-701 (multi-RTK),-0.809433054,red,BL1,0.432832183,0.363680455,10,multi-RTK,RTK,49,AZD8931 (ERBB1/2/3),1.300066148,orange,BL2,0.417413146,0.379433877,180,ERBB1/2/3,RTK,1,EPZ004777 (Dot1L),3.613741533,orange,BL2,0.171865678,0.764810844,162,Dot1L,chromatin,2,Vorinostat (HDAC),1.573499709,orange,BL2,0.139616351,0.855063716,172,HDAC,chromatin,3BX-795 (AURKB/C),2.888002916,orange,BL2,0.012696923,1.896301502,166,AURKB/C,mitosis,4CHIR-99021 (GSK3B),1.613262749,orange,BL2,0.130687691,0.883765313,142,GSK3B,WNT signaling,5Gemcitibine (DNA replication),1.107238654,orange,BL2,0.294112979,0.53148581,165,DNA replication,DNA replication,6Bortezomib (Proteasome),0.650401438,orange,BL2,0.632888513,0.198672787,192,Proteasome,other,7MLN8237 (AURKA),4.930546167,orange,BL2,0.127389537,0.894866241,157,AURKA,mitosis,8Erlotinib (EGFR),0.417749134,orange,BL2,0.693463956,0.158976107,152,EGFR,RTK,9YK 4-279 (RNA helicase A),0.593466408,orange,BL2,0.566049632,0.247145487,193,RNA helicase A,other,10Camptothecin (TOP1),0.928202959,orange,BL2,0.369029636,0.432938755,182,TOP1,DNA replication,11Nutlin-3a (MDM2),0.607239126,orange,BL2,0.554151083,0.256371813,113,MDM2,p53 pathway,12BMS-536924 (IGF-1R),2.615202352,orange,BL2,0.021380047,1.669991349,141,IGF-1R,IGFR,13BI-2536 (PLK1/2/3),0.168807365,orange,BL2,0.869313787,0.060823432,170,PLK1/2/3,mitosis,14BMN-673 (PARP1),1.145354175,orange,BL2,0.278733504,0.554810825,136,PARP1,DNA replication,15PD-173074 (FGFR1/3),1.419631021,orange,BL2,0.179248223,0.746545141,110,FGFR1/3,RTK,16"Obatoclax Mesylate (BCL-2/-XL, MCL-1)",-0.125468075,orange,BL2,0.902072566,0.044758525,154,"BCL-2/-XL, MCL-1",apoptosis,17Vinblastine (Microtubules),-0.248729084,orange,BL2,0.807456587,0.092880818,153,Microtubules,mitosis,18JQ1 (BRD2/3/4),1.326674636,orange,BL2,0.207449973,0.683086617,105,BRD2/3/4,chromatin,19NVP-AUY922 (HSP90),-1.603159702,orange,BL2,0.355051134,0.449709096,131,HSP90,AR,20NVP-BEZ235 (PI3K/mTORC1/2),-0.58540064,orange,BL2,0.568301655,0.245421079,185,PI3K/mTORC1/2,PI3K_mTOR,21OSI-906 (IGF1R),0.157066522,orange,BL2,0.878318383,0.056348028,190,IGF1R,IGFR,22Bicalutamide (AR),-1.097152902,orange,BL2,0.298290788,0.525360159,134,AR,AR,23PLX4720 (BRAF),-0.529785906,orange,BL2,0.605190801,0.218107682,159,BRAF,BRAF,24PF-562271 (FAK),0.408201225,orange,BL2,0.691729091,0.160063959,194,FAK,cytoskeleton,25GDC0941 (PI3K),0.43722487,orange,BL2,0.6686172,0.174822455,144,PI3K,PI3K_mTOR,26Everolimus (mTOR),-0.483891926,orange,BL2,0.648911436,0.187814572,126,mTOR,PI3K_mTOR,27AZ960 (JAK2),-0.26124266,orange,BL2,0.799206886,0.097340783,132,JAK2,other,28AZD8055 (mTORC1/2),0.257082069,orange,BL2,0.80113951,0.09629185,171,mTORC1/2,RTK,29GSK2118436 (BRAF),-0.792424478,orange,BL2,0.446504699,0.350173966,146,BRAF,BRAF,30LY317615 (PKC beta),-0.372314763,orange,BL2,0.717427496,0.144221983,196,PKC beta,other,31Cyclophosphamide (DNA akyl),-3.350878665,orange,BL2,0.020309309,1.692304851,168,DNA akyl,DNA replication,32Bryostatin (PKC),-2.943050526,orange,BL2,0.060361561,1.219239537,103,PKC,other,33Temozolomide (DNA akyl),-2.543942996,orange,BL2,0.051645286,1.28696931,173,DNA akyl,DNA replication,34ZM-447439 (AURKB),-1.954890772,orange,BL2,0.072444255,1.139996052,128,AURKB,mitosis,35PF-4708671 (p70(RSK)),-1.763915297,orange,BL2,0.10121661,0.994748213,181,p70(RSK),RTK,36Carboplatin (DNA akyl),-1.632547434,orange,BL2,0.163492583,0.786501944,187,DNA akyl,DNA replication,37Anastrozole (ER),-1.45791467,orange,BL2,0.170533905,0.768189263,156,ER,other,39Axitinib (multi-RTK),-0.322479795,orange,BL2,0.752216771,0.123656988,102,multi-RTK,RTK,40SB-505124 (TGFbetaR-I),1.574722195,orange,BL2,0.139334205,0.855942256,104,TGFbetaR-I,other,42JNK Inhibitor VIII (JNK),0.280946525,orange,BL2,0.783173098,0.106142239,106,JNK,JNK and p38,44EHT 1864 (Rac GTPases),-0.753094001,orange,BL2,0.468752164,0.329056714,107,Rac GTPases,cytoskeleton,45BIRB 0796 (p38/JNK2),-1.178003529,orange,BL2,0.259910219,0.585176644,108,p38/JNK2,JNK and p38,46AICAR (AMPK agonist),-0.938821053,orange,BL2,0.384060469,0.415600392,109,AMPK agonist,metabolism,47CEP-701 (multi-RTK),2.05252906,orange,BL2,0.06081863,1.215963365,111,multi-RTK,RTK,49AZD8931 (ERBB1/2/3),3.218644592,green,LAR,0.191772066,0.717214653,382,ERBB1/2/3,RTK,1EPZ004777 (Dot1L),11.81032383,green,LAR,0.053775402,1.269416334,364,Dot1L,chromatin,2Vorinostat (HDAC),0.875993325,green,LAR,0.396931554,0.401284376,374,HDAC,chromatin,3BX-795 (AURKB/C),3.228613171,green,LAR,0.006594179,2.180839248,368,AURKB/C,mitosis,4CHIR-99021 (GSK3B),0.149417117,green,LAR,0.883517636,0.053784777,344,GSK3B,WNT signaling,5Gemcitibine (DNA replication),2.61093798,green,LAR,0.025998911,1.585044848,367,DNA replication,DNA replication,6Bortezomib (Proteasome),1.343938028,green,LAR,0.407247433,0.390141645,394,Proteasome,other,7MLN8237 (AURKA),6.42796252,green,LAR,0.098251543,1.007660619,359,AURKA,mitosis,8Erlotinib (EGFR),5.429702132,green,LAR,0.002872538,2.541734169,354,EGFR,RTK,9YK 4-279 (RNA helicase A),0.19498009,green,LAR,0.849313016,0.07093222,395,RNA helicase A,other,10Camptothecin (TOP1),3.221113996,green,LAR,0.006156497,2.210666352,384,TOP1,DNA replication,11Nutlin-3a (MDM2),0.911883201,green,LAR,0.37842996,0.422014488,315,MDM2,p53 pathway,12BMS-536924 (IGF-1R),-0.655728705,green,LAR,0.523434702,0.281137489,343,IGF-1R,IGFR,13BI-2536 (PLK1/2/3),1.072862528,green,LAR,0.30854018,0.510688271,372,PLK1/2/3,mitosis,14BMN-673 (PARP1),2.974499377,green,LAR,0.013938164,1.855794442,338,PARP1,DNA replication,15PD-173074 (FGFR1/3),-0.032187275,green,LAR,0.97481164,0.011079293,312,FGFR1/3,RTK,16"Obatoclax Mesylate (BCL-2/-XL, MCL-1)",0.321334182,green,LAR,0.75306497,0.123167554,356,"BCL-2/-XL, MCL-1",apoptosis,17Vinblastine (Microtubules),0.876791944,green,LAR,0.39651331,0.40174223,355,Microtubules,mitosis,18JQ1 (BRD2/3/4),0.18878262,green,LAR,0.853178473,0.068960111,307,BRD2/3/4,chromatin,19NVP-AUY922 (HSP90),-4.851453293,green,LAR,0.129410054,0.888031982,333,HSP90,AR,20NVP-BEZ235 (PI3K/mTORC1/2),-4.359957519,green,LAR,0.000772657,3.112013528,387,PI3K/mTORC1/2,PI3K_mTOR,21OSI-906 (IGF1R),-2.912241274,green,LAR,0.015505101,1.809525398,392,IGF1R,IGFR,22Bicalutamide (AR),-2.27814148,green,LAR,0.045930606,1.33789782,336,AR,AR,23PLX4720 (BRAF),-2.238343836,green,LAR,0.043329426,1.363217065,361,BRAF,BRAF,24PF-562271 (FAK),-2.230325476,green,LAR,0.049814972,1.302640114,396,FAK,cytoskeleton,25GDC0941 (PI3K),-2.16179493,green,LAR,0.048440218,1.314793908,346,PI3K,PI3K_mTOR,26Everolimus (mTOR),-2.123265678,green,LAR,0.087144262,1.059761203,328,mTOR,PI3K_mTOR,27AZ960 (JAK2),-1.73512204,green,LAR,0.113374102,0.945486139,334,JAK2,other,28AZD8055 (mTORC1/2),-1.707699702,green,LAR,0.111445842,0.952936131,373,mTORC1/2,RTK,29GSK2118436 (BRAF),-1.69566276,green,LAR,0.120807434,0.917906342,348,BRAF,BRAF,30LY317615 (PKC beta),-1.477021678,green,LAR,0.17045554,0.76838888,398,PKC beta,other,31Cyclophosphamide (DNA akyl),-0.446648186,green,LAR,0.673810108,0.171462478,370,DNA akyl,DNA replication,32Bryostatin (PKC),-0.229070027,green,LAR,0.833542579,0.079072211,305,PKC,other,33Temozolomide (DNA akyl),-0.804141659,green,LAR,0.457827087,0.339298516,375,DNA akyl,DNA replication,34ZM-447439 (AURKB),-1.31708639,green,LAR,0.210554096,0.676636306,330,AURKB,mitosis,35PF-4708671 (p70(RSK)),-1.083908091,green,LAR,0.298099271,0.525639085,383,p70(RSK),RTK,36Carboplatin (DNA akyl),0.299989943,green,LAR,0.77625628,0.109994873,389,DNA akyl,DNA replication,37Anastrozole (ER),0.62374486,green,LAR,0.544469845,0.264026168,358,ER,other,39Axitinib (multi-RTK),-0.614359623,green,LAR,0.549579249,0.259969674,304,multi-RTK,RTK,40SB-505124 (TGFbetaR-I),0.577222612,green,LAR,0.573650134,0.241352901,306,TGFbetaR-I,other,42JNK Inhibitor VIII (JNK),1.5737425,green,LAR,0.139560277,0.855238178,308,JNK,JNK and p38,44EHT 1864 (Rac GTPases),-0.110769804,green,LAR,0.913990531,0.039058304,309,Rac GTPases,cytoskeleton,45BIRB 0796 (p38/JNK2),-0.061454736,green,LAR,0.951931841,0.021394146,310,p38/JNK2,JNK and p38,46AICAR (AMPK agonist),0.393424046,green,LAR,0.707605788,0.150208623,311,AMPK agonist,metabolism,47CEP-701 (multi-RTK),-0.496963974,green,LAR,0.627512676,0.202377497,313,multi-RTK,RTK,49AZD8931 (ERBB1/2/3),0.630403198,blue,M,0.641917084,0.192521066,281,ERBB1/2/3,RTK,1EPZ004777 (Dot1L),0.1786348,blue,M,0.887464552,0.051848985,263,Dot1L,chromatin,2Vorinostat (HDAC),0.408529772,blue,M,0.689534311,0.161444118,273,HDAC,chromatin,3BX-795 (AURKB/C),0.284595547,blue,M,0.780437002,0.107662148,267,AURKB/C,mitosis,4CHIR-99021 (GSK3B),-0.148904808,blue,M,0.88391385,0.053590061,243,GSK3B,WNT signaling,5Gemcitibine (DNA replication),0.260585386,blue,M,0.799699652,0.097073093,266,DNA replication,DNA replication,6Bortezomib (Proteasome),1.262602238,blue,M,0.426441717,0.370140317,293,Proteasome,other,7MLN8237 (AURKA),0.107316467,blue,M,0.931940693,0.030611724,258,AURKA,mitosis,8Erlotinib (EGFR),0.020288268,blue,M,0.984598144,0.006740987,253,EGFR,RTK,9YK 4-279 (RNA helicase A),1.341302243,blue,M,0.209489164,0.678838436,294,RNA helicase A,other,10Camptothecin (TOP1),0.655535466,blue,M,0.522750145,0.281705838,283,TOP1,DNA replication,11Nutlin-3a (MDM2),-1.194724097,blue,M,0.253537249,0.595958227,214,MDM2,p53 pathway,12BMS-536924 (IGF-1R),-0.173737345,blue,M,0.864748086,0.063110391,242,IGF-1R,IGFR,13BI-2536 (PLK1/2/3),0.375220766,blue,M,0.715332139,0.145492262,271,PLK1/2/3,mitosis,14BMN-673 (PARP1),-0.262993032,blue,M,0.797895061,0.098054223,237,PARP1,DNA replication,15PD-173074 (FGFR1/3),-1.496130917,blue,M,0.15849758,0.799977364,211,FGFR1/3,RTK,16"Obatoclax Mesylate (BCL-2/-XL, MCL-1)",0.040618131,blue,M,0.96821752,0.014027063,255,"BCL-2/-XL, MCL-1",apoptosis,17Vinblastine (Microtubules),0.037475241,blue,M,0.970675447,0.012925955,254,Microtubules,mitosis,18JQ1 (BRD2/3/4),-1.685746268,blue,M,0.115682076,0.936733925,206,BRD2/3/4,chromatin,19NVP-AUY922 (HSP90),-0.501087599,blue,M,0.704279096,0.152255202,232,HSP90,AR,20NVP-BEZ235 (PI3K/mTORC1/2),0.821416795,blue,M,0.42621699,0.370369243,286,PI3K/mTORC1/2,PI3K_mTOR,21OSI-906 (IGF1R),1.199744364,blue,M,0.25789124,0.58856341,291,IGF1R,IGFR,22Bicalutamide (AR),-0.471992933,blue,M,0.647062457,0.189053798,235,AR,AR,23PLX4720 (BRAF),0.165122364,blue,M,0.871387713,0.059788568,260,BRAF,BRAF,24PF-562271 (FAK),1.465496037,blue,M,0.173508562,0.76067909,295,FAK,cytoskeleton,25GDC0941 (PI3K),-0.128103711,blue,M,0.899888879,0.045811115,245,PI3K,PI3K_mTOR,26Everolimus (mTOR),-0.616204867,blue,M,0.564728089,0.248160611,227,mTOR,PI3K_mTOR,27AZ960 (JAK2),-0.489870828,blue,M,0.634793882,0.197367268,233,JAK2,other,28AZD8055 (mTORC1/2),0.385972337,blue,M,0.705759763,0.151343106,272,mTORC1/2,RTK,29GSK2118436 (BRAF),-0.120956677,blue,M,0.90612125,0.042813685,247,BRAF,BRAF,30LY317615 (PKC beta),1.692217863,blue,M,0.121476856,0.915506457,297,PKC beta,other,31Cyclophosphamide (DNA akyl),0.346695552,blue,M,0.742934239,0.129049626,269,DNA akyl,DNA replication,32Bryostatin (PKC),-1.869351222,blue,M,0.158355223,0.800367607,204,PKC,other,33Temozolomide (DNA akyl),0.476356951,blue,M,0.653908564,0.184482975,274,DNA akyl,DNA replication,34ZM-447439 (AURKB),-0.604069385,blue,M,0.556192951,0.25477452,229,AURKB,mitosis,35PF-4708671 (p70(RSK)),0.648660249,blue,M,0.527850843,0.27748878,282,p70(RSK),RTK,36Carboplatin (DNA akyl),1.075404266,blue,M,0.331325463,0.479745187,288,DNA akyl,DNA replication,37Anastrozole (ER),0.103139166,blue,M,0.919556126,0.036421758,257,ER,other,39Axitinib (multi-RTK),-3.117323209,blue,M,0.008169742,2.087791662,203,multi-RTK,RTK,40SB-505124 (TGFbetaR-I),-1.787769586,blue,M,0.097134385,1.012627007,205,TGFbetaR-I,other,42JNK Inhibitor VIII (JNK),-1.557093805,blue,M,0.143450572,0.843297715,207,JNK,JNK and p38,44EHT 1864 (Rac GTPases),-1.554302946,blue,M,0.15116376,0.820552314,208,Rac GTPases,cytoskeleton,45BIRB 0796 (p38/JNK2),-1.552724528,blue,M,0.144486822,0.840171761,209,p38/JNK2,JNK and p38,46AICAR (AMPK agonist),-1.506816998,blue,M,0.182576321,0.738555549,210,AMPK agonist,metabolism,47CEP-701 (multi-RTK),-1.385302436,blue,M,0.189270171,0.722917824,212,multi-RTK,RTK,49